Videos
The UK DRI’s COO, Adrian Ivinson, discusses the UK DRI and the current dementia care research landscape, as well as new opportunities for dementia researchers to join the Institute.
Filmed at Lilly’s Erl Wood at 50 celebration event, Sue Forda (Lilly, UK) shares highlights from Erl Wood’s 50-year history,…
Whilst at Lilly’s Erl Wood at 50 celebration event, we spoke with Michael Hutton (Lilly, UK). In this video, Michael…
Whilst at Lilly’s Erl Wood at 50 celebration event, we sat down with Dan Skovronsky (Lilly, UK). In this interview,…
Whilst at Lilly’s Erl Wood at 50 celebration event, we sat down with David Reynolds, Chief Scientific Officer at Alzheimer’s…
In this video interview, filmed at Lilly’s Erl Wood at 50 celebration event, Virginia Acha (then Association of the British…
Jeff describes how dysfunction in the glymphatic system could contribute to Alzheimer’s disease, and how our growing knowledge in this area could be harnessed to develop new disease-modifying treatments.
Prof Kipnis describes his lab’s discovery that meningeal vessels directly link the brain with the lymphatic system, overturning decades of teaching that the brain lacks a direct connection to the immune system.
Prof Hardy gives his views on the latest updates in neurodegeneration, including what this year’s results in the aducanumab and solanezumab trials could mean for the search for Alzheimer’s treatments.
Listen to our latest NCTalks podcast with leading neurosurgeon, Ali Rezai, to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade.
